Skip to main content

2016 APEC High Level Meeting on Health and the Economy – Annex 1

HLM6 Joint Statement – Annex 1


  • HLM6 welcomed efforts to monitor Universal Health Coverage (UHC) progress in the APEC region
  • HLM6 welcomed work to address Multi-Drug Resistant Tuberculosis and establish the Asian Tuberculosis Research and Clinical Trials network
  • HLM6 welcomed efforts to build capacity to effectively prevent, detect, and respond to infectious disease threats.


  • HLM6 commended the APEC LSIF Regulatory Harmonization Steering Committee (RHSC)’s strategic and coordinated approach to regulatory convergence and capacity building for medical products.
  • HLM6 welcomed the new operating model and progress in establishing APEC Training Centers of Excellence (CoE) in Regulatory Sciences to support the RHSC’s “Vision 2020” of achieving convergence of regulatory approval procedures for medical products by 2020, which was endorsed in 2011 by APEC Ministers (foreign and trade). To this end HLM6 welcomed the pilot APEC-PKU Health Sciences Academy pilot CoE program for multi-regional clinical trials (MRCT), an additional MRCT pilot at Duke-NUS, biotherapeutics pilot CoE programs underway at Northeastern University and Seoul National University.
  • HLM6 welcomed the ongoing training to help entrepreneurs commercialize their discoveries through the APEC Biomedical Technology Commercialization Training Center.
  • HLM6 welcomed implementation of the Blood Supply Chain 2020 Roadmap and Partnership Training Network
  • HLM6 welcomed progress on finalizing the Global Medical Product Quality and Supply Chain Integrity Roadmap and Associated Toolkits and looked forward to their implementation, including through the establishment of a Regulatory Science Center of Excellence for Quality Standards hosted by United States Pharmacopoeial Convention.


  • HLM6 welcomed the release of the APEC Report on Strategic Needs in Mental Health and called on APEC economies to collaborate with and support the APEC Digital Hub for Mental Health to address the strategic needs identified in the report.  HLM6 reaffirmed its commitment to implement the APEC Roadmap to Promote Mental Wellness in a Healthy Asia-Pacific.       
  • HLM6 welcomed the upcoming work to accelerate action on HPV and Cervical Cancer and looks forward to the finalization of an APEC Roadmap for Implementation of Cervical Cancer Prevention and Control.
  • HLM6 welcomed the proposal to discuss the fiscal and economic impacts of ill-health on the margins of the upcoming Senior Finance Officials Meeting which will determine the shape and content of a formal cross-fora dialogue between the groups and other relevant stakeholders in 2017.


  • HLM6 noted implementation of the APEC Healthy Women, Healthy Economies Policy Toolkit to address health-related barriers to women’s participation in the workforce and called for the continued implementation of the Toolkit’s recommendations on a public-private basis, including through establishment of a private-public steering group to champion further implementation efforts. 


  • HLM6 noted plans to develop an APEC Framework for the Secondary Use of Data in Health and Medical Research in accordance with relevant ethical and data privacy principles.


  • HLM6 noted the Global Data Standards pilot projects to improve supply chain connectivity and integrity and called on APEC economies to volunteer.